Prevalence of germline TP53 mutations in HER2+ breast cancer patients.
about
The Promise of Preventive Cancer VaccinesIntegrated analysis of germline and somatic variants in ovarian cancer.Biologic and clinical characteristics of adolescent and young adult cancers: Acute lymphoblastic leukemia, colorectal cancer, breast cancer, melanoma, and sarcomaNext-generation sequencing for inherited breast cancer risk: counseling through the complexity.Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome.Precision medicine in breast cancer: genes, genomes, and the future of genomically driven treatments.Next generation sequencing is informing phenotype: a TP53 example.
P2860
Q26783742-B55A8DE4-FD99-4258-8651-40E98B85A803Q33630954-892B442E-C373-490E-9538-5BAADB103E41Q36717196-D8D7EA6B-91BB-4CAB-8FC0-014FD9A265F7Q38184454-4AFD81E7-C648-4B86-AF99-6FACA99E978DQ38202612-117367DB-EB3F-4E33-AAC8-E073909FC2B7Q38364614-8F327E68-E88E-4A6A-AE54-29FF7A434E77Q38783154-C296C297-0B4E-423C-BBB6-C95133CFC825
P2860
Prevalence of germline TP53 mutations in HER2+ breast cancer patients.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Prevalence of germline TP53 mutations in HER2+ breast cancer patients.
@ast
Prevalence of germline TP53 mutations in HER2+ breast cancer patients.
@en
Prevalence of germline TP53 mutations in HER2+ breast cancer patients.
@nl
type
label
Prevalence of germline TP53 mutations in HER2+ breast cancer patients.
@ast
Prevalence of germline TP53 mutations in HER2+ breast cancer patients.
@en
Prevalence of germline TP53 mutations in HER2+ breast cancer patients.
@nl
prefLabel
Prevalence of germline TP53 mutations in HER2+ breast cancer patients.
@ast
Prevalence of germline TP53 mutations in HER2+ breast cancer patients.
@en
Prevalence of germline TP53 mutations in HER2+ breast cancer patients.
@nl
P2093
P2860
P1476
Prevalence of germline TP53 mutations in HER2+ breast cancer patients.
@en
P2093
Alexander Miron
Andrea L Richardson
Deborah A Dillon
Ian E Krop
Judy E Garber
Michelle G Rath
Penelope Miron
Rebecca Gelman
Serena Masciari
Sigitas J Verselis
P2860
P2888
P304
P356
10.1007/S10549-012-2375-Z
P407
P577
2013-04-12T00:00:00Z
P6179
1044697020